Parallax Volatility Advisers’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Parallax Volatility Advisers’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-74,400	Closed	-$2.18M	–	3389
2021 Q4	$2.18M	Buy	74,400 +24,200	+48%	+$750K	﹤0.01%	1058
2021 Q3	$1.28M	Buy	+50,200	New	+$1.48M	﹤0.01%	1268
2021 Q1	–	Sell	-23,000	Closed	-$996K	–	2281
2020 Q4	$996K	Buy	+23,000	New	+$1.13M	﹤0.01%	1440
2019 Q4	–	Sell	-18,800	Closed	-$912K	–	2732
2019 Q3	$912K	Sell	18,800 -46,200	-71%	-$2.41M	﹤0.01%	1418
2019 Q2	$3.42M	Sell	65,000 -35,000	-35%	-$2.01M	﹤0.01%	864
2019 Q1	$5.29M	Buy	100,000 +4,100	+4%	+$201K	0.01%	681
2018 Q4	$3.94M	Buy	95,900 +65,900	+220%	+$2.47M	0.01%	785
2018 Q3	$1.14M	Buy	+30,000	New	+$1.33M	﹤0.01%	1223

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Parallax Volatility Advisers's GBT Position: Q4 2022 in Review

Parallax Volatility Advisers sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 5,221 shares — an estimated $356K sold.

Parallax Volatility Advisers first reported a position in GBT in Q2 2016 and held it in 9 quarters. The position peaked at $3.61M in Q2 2018. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Parallax Volatility Advisers reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Parallax Volatility Advisers sold 5,221 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $356K.
Parallax Volatility Advisers first reported a position in Global Blood Therapeutics, Inc. in Q2 2016 and held it in 9 quarters.
Parallax Volatility Advisers's Global Blood Therapeutics, Inc. position peaked at $3.61M in Q2 2018.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Parallax Volatility Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.